About the bill
- Full Title
A bill to prohibit brand name drug companies from compensating generic drug companies to delay the entry of a generic drug into the market.
Legislative action may be ocurring on one of these bills in lieu of or in parallel to action on this bill.
Reported by Committee
Last Action: Oct 15, 2009
- What is a bill?
The “S.” in “S. 27” means this is a Senate bill in the United States Congress. A bill must be passed by both the House and Senate in identical form and then be signed by the President to become law.
The bill’s title was written by its sponsor.
9 cosponsors (6D, 2R, 1I) (show)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Jan 25, 2011)(joined Feb 1, 2011)(joined Feb 1, 2012)
- Committee Assignments
The committee chair determines whether a bill will move past the committee stage.
There have been no votes related to this bill.
- Subject Areas
- Find Similar Bills
Search for similar bills.
Links & tools
Click a format for a citation suggestion:
Civic Impulse. (2015). S. 27 — 112th Congress: Preserve Access to Affordable Generics Act. Retrieved from https://www.govtrack.us/congress/bills/112/s27
“S. 27 — 112th Congress: Preserve Access to Affordable Generics Act.” www.GovTrack.us. 2011. May 28, 2015 <https://www.govtrack.us/congress/bills/112/s27>
|title=S. 27 (112th)
|accessdate=May 28, 2015
|author=112th Congress (2011)
|date=January 25, 2011
|quote=Preserve Access to Affordable Generics Act